基本信息
views: 430

Bio
Dr. Reuben is a leading authority and has conducted significant research on circulating tumour cell subsets, including those with epithelial and mesenchymal phenotypes and their clinical relevance to minimal residual disease in breast cancer and non-small cell lung cancer.
Research Interests
Papers共 640 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2024)
crossref(2024)
crossref(2024)
crossref(2024)
Angela Alexander, Hope Murphy,James Reuben,H. T. Carisa Le-Petross,Deanna Lane,Monica Huang,Savitri Krishnamurthy,Yun Gong,Dan Gombos, Nimisha Patel, Richard Allen,Suyu Liu,Anisha Patel,Andrew Futreal,Ignacio Wistuba,Rachel Layman,Naoto Ueno,Debu Tripathy,Bora Lim,Vicente Valero
Cancer Researchno. 9_Supplement (2024): PO5-06
crossref(2024)
Angela Alexander, Hope Murphy,James Reuben,H. T. Carisa Le-Petross,Deanna Lane,Monica Huang,Savitri Krishnamurthy,Yun Gong,Dan Gombos, Nimisha Patel, Richard Allen,Suyu Liu,Anisha Patel,Andrew Futreal,Ignacio Wistuba,Rachel Layman,Naoto Ueno,Debu Tripathy,Bora Lim,Vicente Valero
CANCER RESEARCHno. 9 (2024)
Angela Alexander, Hope Murphy,James M. Reuben,Huong T. Le-Petross,Deanna L. Lane,Monica L. Huang,Savitri Krishnamurthy, Yun,Dan S. Gombos, Nimisha Patel, R. C. Allen,Suyu Liu,Anisha B. Patel,P. Andrew Futreal,Ignacio Wistuba,Rachel M. Layman,Naoto T. Ueno,Debu Tripathy,Bora Lim,Vicente Valero
Cancer Researchno. 9_Supplement (2024): PO5-02
crossref(2024)
Clinical Cancer Researchpp.OF1-OF9, (2024)
Load More
Author Statistics
#Papers: 640
#Citation: 22531
H-Index: 75
G-Index: 138
Sociability: 8
Diversity: 3
Activity: 31
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn